Dicerna™ Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 145,500 shares of common stock to be distributed among eight new employees, with a grant date of May 1, 2019.